Francesca Russo

Dr. Francesca Russo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Simone La PadulaSimone La Padula
Simone La Padula
MPMartina Ponzo
Martina Ponzo
MLMariagiovanna Lombardi
Mariagiovanna Lombardi
VIVincenzo Iazzetta
Vincenzo Iazzetta
CEConcetta Errico
Concetta Errico
RPRosita Pensato
Rosita Pensato
Nanofat is a relatively novel technique in fat grafting that has gained significant interest in the fields of regenerative medicine, aesthetic and translational research. It involves the extraction of autologous fat from a patient, which is then transformed into “nanofat”, consisting of small fat particles with a diameter of less than 0.1 mm and containing high concentrations of stem cells and growth factors. This article focuses on the use of nanofat in facial rejuvenation and its potential for lipomodelling. Fat tissue is a “stem cell depot” and nanofat contains many stem cells that can differentiate into various cell types. The Lipogem technology, developed in 2013, enables the isolation of nanofat with an intact perivascular structure, utilizing the high concentration of mesenchymal stromal cells near the pericytes of the adipose vascular system. Nowadays nanofat is used primarily for cosmetic purposes particularly in rejuvenating and improving the appearance of the skin, especially the face. Indeed, it has wide applicability; it can be used to treat fine lines, wrinkles, acne scars, sun-damaged skin, scar repair, and as an alopecia treatment. However, further studies are needed to assess the long-term efficacy and safety of this technique. In conclusion, nanofat is a safe and minimally invasive option for tissue regeneration with considerable therapeutic potential. This study reviews the application and effects of nanofat in regenerative medicine and facial cosmetic surgery.

24 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GPGianmarco Polverino
Gianmarco Polverino
FRFrancesca Russo
Francesca Russo
FDFrancesco D’andrea
Francesco D’andrea
Wound management presents a significant global challenge, necessitating a comprehensive understanding of wound care products and clinical expertise in selecting dressings. Bioactive dressings (BD) represent a diverse category of dressings, capable of influencing wound healing through various mechanisms. These dressings, including honey, hyaluronic acid, collagen, alginates, and polymers enriched with polyhexamethylene biguanide, chitin, and chitosan derivatives, create a conducive environment for healing, promoting moisture balance, pH regulation, oxygen permeability, and fluid management. Interactive dressings further enhance targeted action by serving as substrates for bioactive agents. The continuous evolution of BDs, with new products introduced annually, underscores the need for updated knowledge in wound care. To facilitate dressing selection, a practical algorithm considers wound exudate, infection probability, and bleeding, guiding clinicians through the process. This algorithm aims to optimize wound care by ensuring the appropriate selection of BDs tailored to individual patient needs, ultimately improving outcomes in wound management.

21 June 2026 in Aesthetic Plastic Surgery
Verified
Journal Article
Open access
SSSalvatore Taglialatela Scafati
Salvatore Taglialatela Scafati
GPGianmarco Polverino
Gianmarco Polverino
FRFrancesca Russo
Francesca Russo
RRRaffaele Russo
Raffaele Russo
FDFrancesco D’ANdrea
Francesco D’ANdrea
Simultaneous augmentation mastopexy represents one of the most demanding procedures in aesthetic breast surgery, due to the need to balance volume enhancement with tissue tightening. Traditional techniques often struggle to maintain long-term stability, frequently resulting in recurrent ptosis, increased tension on the wound closure, and higher complication and revision rates. The Octopus Mastopexy was developed as a standardized refinement of the inverted-T approach, aiming to provide a reproducible, tension-free result while ensuring reliable nipple–areolar complex vascularization. A retrospective review was conducted of patients who underwent primary or secondary augmentation mastopexy using the Octopus technique between January 2019 and January 2024, all performed by the senior author. The technique is characterized by an implant-first sequence, selective and on-demand parenchymal reduction, and multivector pillar mobilization to evenly redistribute tension across the breast mound. Patient-reported satisfaction and quality-of-life outcomes were assessed using the BREAST-Q questionnaire, administered preoperatively and again at least 12 months postoperatively. Ninety-five patients were included, with a mean age of 39.2 years and a mean implant volume of 300 cc. No major complications occurred. Minor wound dehiscence was observed in two patients and managed conservatively, while six patients required revision for recurrent glandular laxity or weight change. BREAST-Q scores improved significantly across all measured domains, including satisfaction with breasts, physical well-being, and psychosocial well-being. These findings suggest that the Octopus Mastopexy provides a safe, stable, and reproducible solution for simultaneous breast augmentation and mastopexy, improving aesthetic outcomes while reducing tension-related complications and revision rates. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

8 November 2026 in Arthroscopy, Sports Medicine, and Rehabilitation
Verified
Journal Article
Open access
RRRaffaele Russo
Raffaele Russo
AFAlfonso Fedele
Alfonso Fedele
VRValentina Rossi
Valentina Rossi
FRFrancesca Russo
Francesca Russo
CRCesare Russo
Cesare Russo
AGAntonio Guastafierro
Antonio Guastafierro
Purpose: To analyze the healing of equine‐derived xenograft bone blocks with the native glenoid using computed tomography (CT) and to evaluate clinical outcomes in patients undergoing arthroscopic bone block stabilization with xenograft, Bankart repair, and upper‐third subscapularis tenodesis for recurrent anterior shoulder instability with glenoid bone loss. Methods: Patients with recurrent anterior shoulder instability and glenoid bone loss between 12.5% and 25% who underwent arthroscopic equine‐derived xenograft bone block augmentation combined with Bankart repair and upper‐third subscapularis tenodesis between 2019 and 2023 were identified. Minimum clinical and radiological follow‐up was 24 months. Xenograft healing was evaluated on serial CT scans, and clinical outcomes were assessed using Western Ontario Shoulder Instability Index, Rowe, quick Disabilities of the Arm, Shoulder and Hand, and visual analog scale scores. Results: A total of 76 patients (72 men, 4 women) met the inclusion criteria and were analyzed, with a mean clinical follow‐up of 50.7 months (range, 24‐75 months). Radiological follow‐up on CT averaged 46.1 months (range, 24‐72 months). All patients underwent CT imaging according to the study protocol. Western Ontario Shoulder Instability Index improved from 1335.7 ± 136.8 to 134.6 ± 138.2 ( P < .001), with 100% of patients exceeding the minimal clinically important difference (MCID) threshold; Rowe scores increased from 35.3 ± 12.2 to 90.8 ± 11.0 ( P < .001), with 100% surpassing the MCID; mean quick Disabilities of the Arm, Shoulder and Hand improved from 42.6 ± 21.2 to 4.0 ± 4.7 ( P < .001), with 86.8% exceeding the MCID; and visual analog scale decreased from 1.3 ± 1.1 to 0.5 ± 1.1 ( P < .001), with 72.4% of patients reaching the MCID. Recurrence occurred in 4 patients (5.3%) because of high‐energy trauma, and 2 patients presented Samilson‐Prieto grade III osteoarthritis. Despite no radiographic graft‐glenoid fusion being observed in any patient (0/76), graft morphology and volume were maintained without signs of resorption throughout follow‐up. Conclusions: Despite the lack of radiographic union, most patients treated with arthroscopic bone xenograft plus Bankart repair and upper‐third subscapularis tenodesis showed functional improvements surpassing the MCID threshold at a minimum 2‐year follow‐up. Level of Evidence: Level IV, retrospective therapeutic case series.